Table 5 Functions enrichment analysis of GATA family members in ovarian cancer patients
GO | Category | Description | Count | % | Log10(P) | Log10(q) |
|---|---|---|---|---|---|---|
GO:0000976 | GO Molecular Functions | transcription regulatory region sequence-specific DNA binding | 31 | 54.39 | −30.16 | −25.82 |
GO:0008134 | GO Molecular Functions | transcription factor binding | 29 | 50.88 | −29.79 | −25.75 |
GO:0017053 | GO Cellular Components | transcriptional repressor complex | 16 | 28.07 | −25.93 | −22.49 |
GO:0007507 | GO Biological Processes | heart development | 24 | 42.11 | −23.46 | −20.07 |
GO:0048568 | GO Biological Processes | embryonic organ development | 22 | 38.60 | −23.18 | −19.84 |
GO:0004089 | GO Molecular Functions | carbonate dehydratase activity | 9 | 15.79 | −19.73 | −16.59 |
hsa00910 | KEGG Pathway | Nitrogen metabolism | 9 | 15.79 | −19.40 | −16.71 |
GO:0051098 | GO Biological Processes | regulation of binding | 18 | 31.58 | −18.58 | −15.58 |
GO:0009611 | GO Biological Processes | response to wounding | 21 | 36.84 | −17.75 | −14.83 |
GO:0035270 | GO Biological Processes | endocrine system development | 12 | 21.05 | −15.67 | −12.95 |
GO:0008593 | GO Biological Processes | regulation of Notch signaling pathway | 11 | 19.30 | −15.18 | −12.50 |
hsa04330 | KEGG Pathway | Notch signaling pathway | 9 | 15.79 | −14.59 | −12.20 |
GO:0042692 | GO Biological Processes | muscle cell differentiation | 15 | 26.32 | −13.90 | −11.34 |
GO:1903706 | GO Biological Processes | regulation of hemopoiesis | 15 | 26.32 | −13.32 | −10.81 |
GO:2000736 | GO Biological Processes | regulation of stem cell differentiation | 9 | 15.79 | −13.14 | −10.68 |
GO:0003300 | GO Biological Processes | cardiac muscle hypertrophy | 10 | 17.54 | −13.13 | −10.67 |
GO:0001816 | GO Biological Processes | cytokine production | 17 | 29.82 | −12.30 | −9.95 |
hsa04658 | KEGG Pathway | Th1 and Th2 cell differentiation | 9 | 15.79 | −11.91 | −9.92 |
GO:0005667 | GO Cellular Components | transcription factor complex | 13 | 22.81 | −11.56 | − 9.28 |
hsa05169 | KEGG Pathway | Epstein-Barr virus infection | 10 | 17.54 | −10.21 | −8.29 |
hsa05161 | KEGG Pathway | Hepatitis B | 9 | 15.79 | −10.14 | −8.29 |
GO:0048645 | GO Biological Processes | animal organ formation | 7 | 12.28 | −9.74 | −7.59 |
GO:0055001 | GO Biological Processes | muscle cell development | 9 | 15.79 | −9.43 | −7.31 |
GO:0032870 | GO Biological Processes | cellular response to hormone stimulus | 14 | 24.56 | −9.04 | −6.98 |
GO:0009408 | GO Biological Processes | response to heat | 8 | 14.04 | −8.72 | −6.68 |
hsa05321 | KEGG Pathway | Inflammatory bowel disease (IBD) | 4 | 7.02 | −4.71 | −3.66 |
hsa04390 | KEGG Pathway | Hippo signaling pathway | 4 | 7.02 | −3.25 | −2.40 |
hsa05031 | KEGG Pathway | Amphetamine addiction | 3 | 5.26 | −3.20 | −2.37 |
hsa05418 | KEGG Pathway | Fluid shear stress and atherosclerosis | 3 | 5.26 | −2.29 | −1.57 |